PAREXEL Navigates China's Complex Drug Development and Market Landscape for Global Biopharmaceutical Companies with New China Advisory Service

BOSTON, October 31, 2018 – PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today announced that the Company has launched a new China Advisory Service to help global biopharmaceutical companies participate in the growing, yet complex market opportunity within China. The offering leverages PAREXEL’s deep experience with and knowledge of the Chinese biopharmaceutical landscape to help companies navigate all aspects of the country’s drug development process. This includes overall strategy, agency engagement and... Source: RealWire